• FirefoxInstall the new Firefox »
  •  Dow Down 0.06% Nasdaq Up 0.42%

    Merrimack Pharmaceuticals, Inc. (MACK)

    -NasdaqGM
    10.77 Down 0.08(0.74%) Feb 26, 4:00PM EST
    Add to Portfolio
    Prev Close:10.85
    Open:11.02
    Bid:10.74 x 500
    Ask:12.50 x 300
    1y Target Est:13.83
    Beta:1.32
    Earnings Date:Apr 29 - May 4 (Est.)
    Day's Range:10.24 - 11.19
    52wk Range:4.13 - 12.00
    Volume:1,331,145
    Avg Vol (3m):1,677,990
    Market Cap:1.14B
    P/E (ttm):N/A
    EPS (ttm):-1.03
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for MACK

    Comparison

    Symbol% ChgMkt Cap
    MACKDown 0.74%1.14B
    IMMUUp 0.49%381.95M
    LRUSF 0.00%N/A
    THLDUp 1.14%277.98M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):14.98
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.98
    Quarterly EPS Est (Mar-15) :-0.23
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):-1.96

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, is engaged in discovering, developing, and preparing to commercialize medicines paired with companion diagnostics for the treatment of cancer primarily in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback